iQOS Modified Risk Tobacco Product application – comment to FDA

December 2017: United States

Comment on PMI Modified Risk Tobacco Product Application

17 experts comment to FDA on the case for allowing Philip Morris International to make reduced exposure, reduced risk and reduced harm claims for its iQOS heat-not-burn product.

See applications details on the FDA website and comments at the docket for this consultation.

Tracking number:  1k1-90b4-vqsh

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Scroll to Top